Investment Research Firm Reports on "Lupus Pipeline"

Yet another sign that lupus is being recognized as an opportunity for pharmaceutical investors. A medical industry marketing group called "Life Science Analytics" is publishing a report called "Systemic Lupus Erythematosus Therapy Area Pipeline Report".

This has to be good news; right? These guys are reporting to investors about what is in the lupus drug pipeline -- concept, development, testing status, FDA approval status, and so on.  We'll take the implication that lupus is getting closer to getting the attention it from the needed investors so that the pharmaceutical companies will get lupus research in gear.

Yay. ?

4 Comments

Thank you for another great article.Where else could anyone get that type of info in such a perfect way of writing? I've a presentation next week, and I'm on the look for such information

Hey Admin/ Site Owner, This is an awesome blog. If you might ever need any backlinks visit- http://bit.ly/10k-backlinks .You would get 10,000 + links for $5, and you'll see amazing result for this awesome site! Cheers & Wish your site all the success.

Hey Admin/ Site Owner, This is an awesome blog. If you might ever need any backlinks visit- http://bit.ly/10k-backlinks .You would get 10,000 + links for $5, and you'll see amazing result for this awesome site! Cheers & Wish your site all the success.

I’ve lately began a weblog, the data you present on this web site has helped me tremendously. Thank you for your whole time & work.

Leave a comment



About

This time, it IS lupus

Archives


 

Recent Entries